Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs

Gut

Volumn 51, Issue 3, 2002, Pages 336-343

  Hawkey, C J ^a   Naesdal J ^b   Wilson, I ^b   Langstrom G ^b   Swannell, A J ^c   Peacock, R A ^b   Yeomans, N D ^d  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; RANITIDINE;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE PREDISPOSITION; DRUG EFFICACY; ENDOSCOPY; GASTRODUODENAL ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; PEPTIC ULCER; PRIORITY JOURNAL; REGRESSION ANALYSIS; RELAPSE; RISK FACTOR; STOMACH EROSION; TREATMENT FAILURE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; COHORT STUDIES; DUODENAL ULCER; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; MULTIVARIATE ANALYSIS; OMEPRAZOLE; RANITIDINE; RECURRENCE; RISK FACTORS; STOMACH ULCER; TREATMENT FAILURE;

EID: 0036719939     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.3.336     Document Type: Article

References (41)

1. Non steroidal anti-inflammatory drugs and peptic ulcers. Facts and figures multiply, but do they add up?
2. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
3. Non-steroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
4. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
5. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
6. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons
7. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
8. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs
9. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: An overview of epidemiologic studies published in the 1990s
10. Quantitative estimation or rare adverse events which follow a biological progression. A new model applied to chronic NSAID use
11. Peptic ulcer bleeding: Accessory risk factors and interactions with non-steroidal anti-inflammatory drugs
12. Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs
13. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease
14. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates
15. Risk factors associated with refractory peptic ulcers
16. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
17. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study
18. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
19. A comparison of omeprazole and ranitidine for treating and preventing ulcers associated with non-steroidal anti-inflammatory drugs
20. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users
21. Helicobacter pylori eradication in patients taking non-steroidal, anti-inflammatory drugs: The HELP NSAIDs Study
22. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users
23. COX-1-sparing NSAIDs is the enthusiasm justified?
24. Tripotassium dicitratobismuthate chewing tablets and cimetidine and DeNol
25. Histological maturity of healing duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine
26. The relationship between endoscopic findings of gastric ulcer scar and ulcer relapse
27. Endoscopic ultrasonographic (EUS) evaluation of the quality of gastric ulcer healing
28. Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment
29. Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole
30. Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen
31. Profound spatial clustering of simultaneous peptic ulcers
32. A possible dual control mechanism in the origin of peptic ulcer. A study on ulcer location as affected by mucosa and musculature
33. Blood supply to the human gastroduodenal mucosa with special reference to the ulcer-bearing areas
34. Temporal relationship between cyclooxygenase inhibition, as measured by prostacylin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat
35. Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
36. High-close ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs
37. On dissonances, Helicobacter pylori and NSAIDs
38. Reply - On dissonances, Helicobacter pylori and NSAIDs
39. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme